Acute and prolonged changes in lipoprotein profile in human volunteers treated with single ascending doses of MDCO-216 (apoA1-MILANO/POPC). Issue 1 (July 2015) - Kempen, H.; Asztalos, B.F.; Jeyarajah, E.; Otvos, J.; Gomaraschi, M.; Calabresi, L.; Kallend, D.; Bobillier, A.; Bellibas, S.; Wijngaard, P.